Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
Dendritic cells instruct different types of T cell responses depending on the types of microbial ligands sensed. Here the authors show that dendritic cells stimulated via Dectin-1 receptor upregulate TNFSF15 and OX40L and induce T helper 9 response and efficient antitumour immunity in mouse models.
Guardado en:
Autores principales: | Yinghua Zhao, Xiao Chu, Jintong Chen, Ying Wang, Sujun Gao, Yuxue Jiang, Xiaoqing Zhu, Guangyun Tan, Wenjie Zhao, Huanfa Yi, Honglin Xu, Xingzhe Ma, Yong Lu, Qing Yi, Siqing Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/59baace985754d9f831df4c17c10a877 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Wenyan Fu, et al.
Publicado: (2019) -
Inhibition of Dectin-1 on Dendritic Cells Prevents Maturation and Prolongs Murine Islet Allograft Survival
por: Ren A, et al.
Publicado: (2021) -
Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
por: Rodrigo Vazquez-Lombardi, et al.
Publicado: (2017) -
Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Raffaella Rossin, et al.
Publicado: (2018) -
Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Raffaella Rossin, et al.
Publicado: (2019)